CAR-T and engineered T cell therapies

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

249 papers

Active filtersClassification:Core

Showing 61-72 of total 249 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedDirectly related

Immune checkpoint knockout screen reveals TIGIT-CD155 interaction as a significant modulator of adapter CAR-T cell function in acute myeloid leukemia.

Mast AS; Atar D; Ruoff L; Scheuermann S; Kristmann B; Lang P; Seitz CM; Schlegel P

2026PubMedDirectly related

Tumor-associated macrophages in gastric cancer peritoneal metastasis: orchestrating immune evasion, niche remodeling, and therapeutic resistance.

Chen M; Li Y; Wang H; Li X; Shen Q; Yang L

Jan 1, 2026Frontiers in immunology

2026PubMedDirectly related

HIV-driven tumor ecosystem: from chronic immune dysfunction to cancer evolution.

Zhou G; Liao J; Tang H; Hou X; Li Q; Li X

Jan 1, 2026Frontiers in microbiology

2026PubMedDirectly related

Association between CAR T-cell persistence and improved response to salvage radiotherapy in patients with DLBCL.

Fan J; Kutsch N; Heger JM; Gödel P; Heger E; Gruell H; Linde P; Ferdinandus S; Rosenbrock J; Dapper H; Fokas E; Borchmann P; Baues C

Jan 1, 2026Acta oncologica (Stockholm, Sweden)

2026PubMedDirectly related

Outcomes of locally produced donor-derived anti-CD19 chimeric antigen receptor T-cells in relapsed or refractory B-cell acute lymphoblastic leukemia patients.

Tannumsaeng S; Anurathapan U; Sermcheep A; Kanjanakan P; Takpradit C; Sanpakit K; Niparuck P; Piyajaroenkij T; Tantiworawit A; Atjanasuppat K; Sawaisorn P; Preedagasamzin S; Jittorntrum B; Prasongtanakij S; Pakakasama S; Hongeng S

Jan 1, 2026Cancer chemotherapy and pharmacology

2026PubMedDirectly related

Cancer-Testis Antigens in Immuno Oncology Mechanisms Therapeutic Strategies and Clinical Perspectives.

Shi R; Ran L; Song T; Zhou X; Zhao W; Zhang Y

Jan 1, 2026Journal of immunology research

2026PubMedDirectly related

Cancer-Testis Antigens in Immuno Oncology Mechanisms Therapeutic Strategies and Clinical Perspectives.

Shi R; Ran L; Song T; Zhou X; Zhao W; Zhang Y

Jan 1, 2026Journal of immunology research

2026PubMedSupporting evidence

Structural Foundation of CTLA-4 antibodies: Emerging Platforms for Next-generation Cancer Immunotherapy.

Leta EM; Syed S; Binegde GN; Gu D; Xiong J; Wang F

Jan 1, 2026International immunopharmacology

2026PubMedDirectly related

Vitamin C enhances cytotoxicity of CAR-and εTRuC-engineered γδ T cells and modulates Ca(2+), NFAT, NF-κB and ERK signaling in human γδ T cells.

Zarobkiewicz M; Ma L; Juraske C; Cierna L; Kouakanou L; Krißmer SM; Fiala GJ; Peters C; Schamel WW; Kabelitz D

Jan 1, 2026Frontiers in immunology

2026PubMedDirectly related

Advances in CAR-T Cell Therapy: From Structural Design Innovations to Clinical Translation Challenges.

Gao H; Fang Y; Zhang P; Qian Q

Jan 1, 2026Journal of Cancer

2026PubMedDirectly related

Engineered Bacteriophages in Cancer Immunotherapy: Emerging Concepts and Potential Integration with CAR-T Cell Therapy.

Alrahimi J

Jan 1, 2026Folia biologica

2026PubMedDirectly related

Biomaterial Techniques for Enhancing CAR-T Cell Therapy of Solid Tumours.

Chilvers K; Maher J

Jan 1, 2026Cancers